Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.
about
Management of gastric and duodenal neuroendocrine tumorsMetronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinomaNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewEndoscopic diagnosis and management of type I neuroendocrine tumorsGastroenteropancreatic high-grade neuroendocrine carcinomaEvaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients.Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinomaThe epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumorsEndoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis.Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine TumorsPrognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters.Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single InstituteThe Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resectionProposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parametersThe Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution.Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center ExperienceGenomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era.Role of radiotherapy for pancreatobiliary neuroendocrine tumors.Which endoscopic treatment is the best for small rectal carcinoid tumors?The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics.Clinical features and management of type I gastric carcinoids.Mixed large cell neuroendocrine carcinoma and adenocarcinoma with spindle cell and clear cell features in the extrahepatic bile duct.Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors.Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report.
P2860
Q26738541-174B77E2-08A9-4D9D-877B-84074BEF3BDAQ26753070-4AD3888C-1FA4-41AE-B9EC-105ED810A3D6Q26768483-D29445A5-F424-44D5-B0B2-F4DE91E00070Q26824302-F5A06CEC-91DF-41C7-8796-A18D710E2549Q26998392-DD103AEA-3826-4239-A59D-A5129FDB66F7Q31064727-0D5D4297-DA72-42D8-8034-B2B20592A3A6Q31095566-18650852-3345-42E1-BA61-B0807A857574Q33648996-54DBE3AA-1BDE-406F-B2BF-C40B6B7812F6Q33901099-0DA64CDB-A84C-41F4-B24E-5B49E0EBDF8FQ33925601-B0EC5314-1295-41EE-90CA-2925F98B0EBBQ33936290-0467E3F8-A1B3-489F-A5AE-F86F6210DD12Q34048330-A704FCC1-B5BE-4DCC-BAC8-F5393692400EQ34157385-E0EB1486-9F70-4C3C-98CA-DC414FF8850EQ34484273-77CD1FA8-8046-4EC3-B39C-B20991CC692EQ34685863-06AE8D7D-8ED7-4260-A7C1-6EE114AB90C2Q35919281-ABE66287-17F1-47A0-9BD8-26EB1313B3CAQ36066143-E380DEFF-AB65-47DF-8835-1316AF0991E5Q36129201-87658CCC-8FEB-46DA-A3C9-D3759736C869Q36153131-EC819D2F-913D-43F2-943B-9C82DC83A3DDQ36187039-8279A714-5199-4995-AEAA-8149DC464B4CQ36187104-55A8917E-3BE0-4C06-9860-2EC4448D32B5Q36657306-36C21972-E36B-4D5E-BDBB-952333A0DE64Q36849357-AAEFC4DF-3D9B-4C54-BF41-D0AE1E4B41B9Q36949021-F80D9F36-5E96-4827-B596-5347D883F856Q36983412-08CF525F-FA70-4AD2-8C82-F194C8F23A23Q36993386-B6174673-40F5-4BE3-B16F-D72358943893Q37000198-D6B999DF-85FB-4D70-83DD-5ECD839D650AQ37015704-52014323-4B7C-441F-8C5F-66E2ED24AA16Q37231180-5BE931DA-A97A-4B0C-B123-A20366644051Q37232740-5614CA5A-BBCE-42EA-98DC-654D7B32DA0BQ37400665-8CA5E77F-8C5D-4C0B-8174-50A70FDD21D4Q37624511-79423AF1-FF10-4F0F-9476-3D6FCD730F05Q37714364-291C84B4-B073-4FC3-81C8-991B44FC2547Q38227725-DE83EF4E-386A-43B5-82A8-D51512BBBE04Q38548932-8A4799C7-1DAF-4ACE-AC3C-106D7B55B4FBQ38784436-8E890B0B-9FE2-4FD6-AF7E-D7CCE341804CQ40200855-E625522A-C023-4E0E-A1B6-EC967BE56889Q40206906-055A4D85-48FB-43BB-B2A2-7E453FD65119Q41116660-4BDCC0D8-658F-4530-905E-956BC1444C44Q41302764-F02FF0F6-40FA-40D8-9316-093E9DB85D92
P2860
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@ast
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@en
type
label
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@ast
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@en
prefLabel
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@ast
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@en
P2093
P2860
P1476
Current Trends of the Incidenc ...... 2000-2009: Multicenter Study.
@en
P2093
Chang Ho Cho
Dae Young Kang
Do Youn Park
Eun Sun Jung
Gastrointestinal Pathology Study Group of Korean Society of Pathologists
Han Ik Bae
Hee Kyung Kim
Heekyung Chang
Hyunki Kim
Jae Hyuk Lee
P2860
P304
P356
10.4143/CRT.2012.44.3.157
P577
2012-09-30T00:00:00Z